{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:49Z","timestamp":1793600869633,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaad.2026.03.078","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:13:55Z","timestamp":1774628035000},"page":"127-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunosuppressive agents in solid organ transplantation: Cutaneous adverse effects and dermatologic considerations"],"prefix":"10.1016","volume":"95","author":[{"given":"Olivia Marie","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco H.","family":"Cabeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Jaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2026.03.078_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management","volume":"41","author":"Pilch","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2026.03.078_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/ajt.16210","article-title":"The burden of cutaneous disease in solid organ transplant recipients of color","volume":"21","author":"Kentley","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jceh.2022.06.007","article-title":"Immunosuppressive drugs in liver transplant: an Insight","volume":"12","author":"Panackel","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101345","article-title":"Basics and art of immunosuppression in liver transplantation","volume":"14","author":"Poudel","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib5","article-title":"Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients","volume":"1","author":"Hill","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2026.03.078_bib6","first-page":"726","article-title":"Immunosuppressive drugs","volume":"4","author":"Hussain","year":"2022","journal-title":"Encyclopedia Infect Immun"},{"key":"10.1016\/j.jaad.2026.03.078_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.13263","article-title":"Normothermic regional perfusion in controlled donation after circulatory death liver transplantation: a systematic review and meta-analysis","volume":"37","author":"Mastrovangelis","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib8","first-page":"30","article-title":"Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?","volume":"30","author":"Niemann","year":"2025","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/cells12030382","article-title":"Antithymocyte globulin inhibits CD8(+) T cell effector functions via the paracrine induction of PDL-1 on monocytes","volume":"12","author":"Copic","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jaad.2026.03.078_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.TP.0000045223.66828.FA","article-title":"Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation","volume":"75","author":"Di Filippo","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/lt.20085","article-title":"Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients","volume":"10","author":"Tector","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib12","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.transproceed.2004.10.003","article-title":"Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C","volume":"36","author":"Kamar","year":"2004","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2026.03.078_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0012.2005.00375.x","article-title":"Thymoglobulin induction protects liver allografts from ischemia\/reperfusion injury","volume":"19","author":"Bogetti","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lt.21098","article-title":"Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review","volume":"13","author":"Lundquist","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib15","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/TP.0b013e318274ab85","article-title":"Serum sickness after antithymocyte globulin administration in a cardiac transplant patient","volume":"94","author":"Rizkallah","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.TP.0000165093.13046.B3","article-title":"Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange","volume":"80","author":"Tanriover","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.24788","article-title":"Presumptive serum sickness as a complication of rabbit-derived antithymocyte globulin immunosuppression","volume":"61","author":"Snow","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2026.03.078_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ajkd.2009.06.017","article-title":"Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure","volume":"55","author":"Boothpur","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2026.03.078_bib19","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/ndt\/12.10.2133","article-title":"Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients","volume":"12","author":"Prin Mathieu","year":"1997","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib20","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1046\/j.1523-1755.1998.00094.x","article-title":"Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation","volume":"54","author":"Cantarovich","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib21","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/ndt\/15.10.1673","article-title":"Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation","volume":"15","author":"Cantarovich","year":"2000","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1399-0012.2003.00102.x","article-title":"Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy","volume":"17","author":"B\u00fcchler","year":"2003","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0190-9622(85)70182-X","article-title":"Cutaneous manifestations of serum sickness in patients receiving antithymocyte globulin","volume":"13","author":"Bielory","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib26","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/ndt\/gfw368","article-title":"Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects","volume":"32","author":"Bamoulid","year":"2017","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib27","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.transproceed.2021.01.010","article-title":"Removal of anti-thymocyte globulin by Plasma Exchange in ABO-Incompatible and positive crossmatch kidney transplant recipients","volume":"53","author":"West-Thielke","year":"2021","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2026.03.078_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/cei.13208","article-title":"Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis","volume":"194","author":"Li","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2026.03.078_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/CPJ.0000000000001126","article-title":"Skin autoimmunity secondary to Alemtuzumab in a tertiary care Spanish Hospital","volume":"12","author":"L\u00f3pez Ruiz","year":"2022","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.jaad.2026.03.078_bib30","doi-asserted-by":"crossref","first-page":"e2233","DOI":"10.1212\/WNL.0000000000006648","article-title":"Vitiligo after alemtuzumab treatment: secondary autoimmunity is not all about B cells","volume":"91","author":"Ruck","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2026.03.078_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1460-9592.2008.02555.x","article-title":"Acute hypersensitivity reaction on re-exposure to basiliximab in an infant undergoing heart transplantation","volume":"18","author":"Wouters","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jaad.2026.03.078_bib33","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.1390055","article-title":"Calcineurin inhibitors: 40 years later, can't live without","volume":"191","author":"Azzi","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2026.03.078_bib34","first-page":"24","article-title":"Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients","volume":"172","author":"Bencini","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2026.03.078_bib35","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.transproceed.2016.02.051","article-title":"Benign cutaneous disease among Polish renal transplant recipients","volume":"48","author":"Imko-Walczuk","year":"2016","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2026.03.078_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1432-2277.2011.01308.x","article-title":"Nonneoplastic mucocutaneous lesions in organ transplant recipients","volume":"24","author":"Ponticelli","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1468-3083.2010.03814.x","article-title":"Prevalence of benign cutaneous disease among Oxford renal transplant recipients","volume":"25","author":"Lally","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.03.078_bib38","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00467-007-0586-z","article-title":"Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis","volume":"22","author":"Webb","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jaad.2026.03.078_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2230.2007.02386.x","article-title":"Hypertrophic pseudofolliculitis in white renal transplant recipients","volume":"32","author":"Lally","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archdermatol.2009.98","article-title":"Cyclosporine-induced infantile nodulocystic acne","volume":"145","author":"Strahan","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mc.20744","article-title":"Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGF\u03b2 signaling pathway","volume":"50","author":"Walsh","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jaad.2026.03.078_bib42","article-title":"Evaluating kaposi sarcoma in kidney transplant patients: a systematic review and meta-analysis","volume":"16","author":"Saowapa","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jaad.2026.03.078_bib43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2019.03.028","article-title":"Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study","volume":"81","author":"Delyon","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib44","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.transproceed.2005.03.144","article-title":"Kaposi sarcoma in solid organ transplant recipients: a single center report","volume":"37","author":"Boeckle","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2026.03.078_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4103\/JIPO.JIPO_10_19","article-title":"Kaposi's Sarcoma in the immunosuppressed","volume":"2","author":"Reddy","year":"2019","journal-title":"J Immunother Prec Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib46","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/01.tp.0000181195.67084.94","article-title":"Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients","volume":"80","author":"Tricot","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdin.2025.01.014","article-title":"Alopecia areata in solid organ transplant recipients: a retrospective analysis","volume":"20","author":"Roman","year":"2025","journal-title":"JAAD Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib48","article-title":"Mycophenolate mofetil: an update on its mechanism of action and effect on lymphoid tissue","volume":"15","author":"Krawczyk","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.03.078_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2230.1995.tb01343.x","article-title":"Azathioprine hypersensitivity-like reactions--a case report and a review of the literature","volume":"20","author":"Knowles","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib51","doi-asserted-by":"crossref","DOI":"10.14309\/crj.0000000000000990","article-title":"Azathioprine-Induced hypersensitivity vasculitis","volume":"10","author":"Sangiorgio","year":"2023","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.jaad.2026.03.078_bib52","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/ard.60.7.719a","article-title":"Azathioprine hypersensitivity","volume":"60","author":"Sofat","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2026.03.078_bib53","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1111\/ajt.14337","article-title":"Cutaneous toxicities from transplantation-related medications","volume":"17","author":"Ilyas","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib54","article-title":"Mycophenolate mofetil-induced aphthous stomatitis after Kidney Transplant: a clinical case report","volume":"15","author":"Almeslet","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaad.2026.03.078_bib55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2146\/ajhp100276","article-title":"Oral ulcers associated with mycophenolate mofetil use in a renal transplant recipient","volume":"68","author":"Weng","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2026.03.078_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jdcr.2015.06.005","article-title":"Mycophenolate mofetil-induced oral ulcerations in solid organ transplant recipients: a report of 3 cases","volume":"1","author":"Salik","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2026.03.078_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2165\/00003495-199039010-00005","article-title":"Pharmacological management of recurrent oral mucosal ulceration","volume":"39","author":"Burgess","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2026.03.078_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/scd.12522","article-title":"Diagnosis and management of oral ulcerations associated with mycophenolate mofetil in kidney transplantation","volume":"40","author":"Ten\u00f3rio","year":"2020","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.jaad.2026.03.078_bib59","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00417-005-0066-8","article-title":"Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients","volume":"244","author":"Siepmann","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jaad.2026.03.078_bib60","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM200010193431604","article-title":"Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group","volume":"343","author":"Chan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.03.078_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5262\/tndt.2014.1001.12","article-title":"Mycophenolate-Associated Alopecia in an adolescent girl mycophenolate and Alopecia","volume":"23","author":"Kasap Demir","year":"2014","journal-title":"Turkish Nephrol Dial Transplant"},{"key":"10.1016\/j.jaad.2026.03.078_bib62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2011.03751.x","article-title":"Reversal of UVA skin photosensitivity and DNA damage in kidney transplant recipients by replacing azathioprine","volume":"12","author":"Hofbauer","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib63","doi-asserted-by":"crossref","first-page":"e239099","DOI":"10.1136\/bcr-2020-239099","article-title":"Azathioprine hypersensitivity syndrome: report of two cases","volume":"14","author":"McKenzie","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2026.03.078_bib64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/joneph\/16.2.272","article-title":"Azathioprine hypersensitivity: report of two cases and review of the literature","volume":"16","author":"Sinico","year":"2003","journal-title":"J Nephrol"},{"key":"10.1016\/j.jaad.2026.03.078_bib65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaad.2010.04.041","article-title":"The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome","volume":"65","author":"Bidinger","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib66","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2169\/internalmedicine.51.6962","article-title":"Azathioprine hypersensitivity presenting as cardiogenic shock and Sweet's syndrome in a patient with microscopic polyangiitis","volume":"51","author":"Turow","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2026.03.078_bib67","first-page":"E7","article-title":"Azathioprine hypersensitivity presenting as neutrophilic dermatosis and erythema nodosum","volume":"98","author":"Cheraghi","year":"2016","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2026.03.078_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215192","article-title":"Azathioprine-induced bullous Sweet's syndrome: a rare association","volume":"2016","author":"Biswas","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaad.2026.03.078_bib69","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jamadermatol.2013.137","article-title":"Neutrophilic dermatosis after azathioprine exposure","volume":"149","author":"Cyrus","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jdv.12041","article-title":"Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases","volume":"28","author":"van den Reek","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.03.078_bib71","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaad.2026.03.078_bib72","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1007\/s12094-024-03839-0","article-title":"Azathioprine and risk of non-melanoma skin cancers in organ transplant recipients: a systematic review and update meta-analysis","volume":"27","author":"Kreuz","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaad.2026.03.078_bib74","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1158\/0008-5472.CAN-09-0299","article-title":"Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin","volume":"69","author":"Yu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2026.03.078_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663602","article-title":"Conversion from calcineurin inhibitors to Mammalian target of Rapamycin inhibitors in kidney transplant recipients: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2026.03.078_bib76","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil","volume":"75","author":"van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bbmt.2014.11.680","article-title":"Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease","volume":"21","author":"Villa","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010068","article-title":"A new Hypothesis describing the pathogenesis of oral mucosal injury associated with the Mammalian target of Rapamycin (mTOR) inhibitors","volume":"16","author":"Sonis","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaad.2026.03.078_bib79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2026.03.078_bib81","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oraloncology.2011.08.009","article-title":"Clinical presentation and management of mTOR inhibitor-associated stomatitis","volume":"47","author":"de Oliveira","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib82","first-page":"28","article-title":"Local presence of cytomegalovirus and Candida species vs oral lesions in liver and kidney transplant recipients","volume":"13","author":"Olczak-Kowalczyk","year":"2008","journal-title":"Ann Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14664","article-title":"Prevalence and spectrum of infectious and inflammatory dermatologic conditions occurring in pediatric heart transplant patients on a predominantly mTOR-based immune suppressive regimen: a retrospective chart review","volume":"28","author":"Rydberg","year":"2024","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2005.11.1072","article-title":"Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects","volume":"55","author":"Mah\u00e9","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.trre.2014.03.002","article-title":"Strategies for the management of adverse events associated with mTOR inhibitors","volume":"28","author":"Kaplan","year":"2014","journal-title":"Transpl Rev (Orlando)"},{"key":"10.1016\/j.jaad.2026.03.078_bib87","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/jdv.15860","article-title":"Erosive pustular dermatosis of the scalp associated with Sirolimus","volume":"34","author":"Khanna","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.03.078_bib88","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.ajkd.2009.09.004","article-title":"Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial","volume":"55","author":"Franz","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2026.03.078_bib89","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib90","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ajt.14186","article-title":"Early conversion from calcineurin Inhibitor- to everolimus-based therapy following Kidney Transplantation: results of the randomized ELEVATE trial","volume":"17","author":"de Fijter","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib91","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1432-2277.2010.01094.x","article-title":"Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial","volume":"23","author":"Dantal","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib92","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib93","article-title":"Mammalian target of Rapamycin inhibitors and wound healing complications in Kidney Transplantation: old myths and new realities","volume":"2022","author":"Mabood Khalil","year":"2022","journal-title":"J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib94","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transpl"},{"issue":"2 Suppl 1","key":"10.1016\/j.jaad.2026.03.078_bib95","article-title":"Comparability of pattern of occurrence of pericardial effusions between everolimus- and MMF-based regimen in de novo cardiac transplant recipients","volume":"28","author":"Lehmkuhl","year":"2009","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib96","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/01.TP.0000162433.34739.61","article-title":"Clinical experience with everolimus (Certican): optimizing dose and tolerability","volume":"79","author":"Pascual","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib97","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.TP.0000118406.01509.75","article-title":"Lymphedema associated with sirolimus in renal transplant recipients","volume":"77","author":"Aboujaoude","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib98","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.transproceed.2004.12.180","article-title":"Severe limb lymphedema in sirolimus-treated patients","volume":"37","author":"Romagnoli","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jaad.2026.03.078_bib99","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamadermatol.2014.158","article-title":"Chronic lymphedema in renal transplant recipients under immunosuppression with sirolimus: presentation of 2 cases","volume":"150","author":"Baliu","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib100","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.12659\/AJCR.905962","article-title":"Lymphedema of the transplanted kidney and abdominal Wall with ipsilateral pleural effusion following kidney Biopsy in a patient treated with sirolimus: a case report and review of the literature","volume":"18","author":"Rashid-Farokhi","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jaad.2026.03.078_bib101","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.annder.2015.01.020","article-title":"[Sirolimus-induced lymphedema in a kidney-transplant recipient: partial recovery after changeover to tacrolimus]","volume":"142","author":"Al Gain","year":"2015","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2026.03.078_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/lrb.2014.0005","article-title":"Large-volume sirolimus-induced upper limb lymphedema after renal transplantation ipsilateral to the arteriovenous fistula","volume":"12","author":"Vignes","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.jaad.2026.03.078_bib103","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1365-2133.2009.09098.x","article-title":"Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism","volume":"160","author":"Desai","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib104","doi-asserted-by":"crossref","first-page":"296","DOI":"10.6002\/ect.2011.0139","article-title":"Everolimus-induced lymphedema in a renal transplant recipient: a case report","volume":"10","author":"Ersoy","year":"2012","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.revmed.2018.04.018","article-title":"[Lymphedema in patients treated with sirolimus: 15 cases]","volume":"40","author":"Fourgeaud","year":"2019","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaad.2026.03.078_bib106","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/ajt.12511","article-title":"Palmoplantar peeling secondary to sirolimus therapy","volume":"14","author":"Liu","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib107","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.rmed.2009.01.003","article-title":"The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use","volume":"103","author":"Manson","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jaad.2026.03.078_bib108","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib109","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in Kidney Transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.03.078_bib110","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/TP.0000000000002247","article-title":"Belatacept and autoimmune adverse events","volume":"102","author":"Ville","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib111","first-page":"355","article-title":"Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection","volume":"6","author":"Ippoliti","year":"2012","journal-title":"Biologics"},{"key":"10.1016\/j.jaad.2026.03.078_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311935","article-title":"Patterns of belatacept use and risk of post-transplant lymphoproliferative disorder in US kidney transplant recipients: an analysis of the Organ Procurement and Transplantation Network database","volume":"20","author":"Cherikh","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2026.03.078_bib113","article-title":"Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression","volume":"2","author":"Koff","year":"2023","journal-title":"Front Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib114","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/bloodadvances.2023011626","article-title":"Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol","volume":"8","author":"Nikiforow","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaad.2026.03.078_bib115","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaad.2019.09.070","article-title":"Belatacept reduces skin cancer risk in kidney transplant recipients","volume":"82","author":"Wang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib116","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaad.2024.05.068","article-title":"De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy","volume":"91","author":"Jew","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1146002","article-title":"Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation","volume":"13","author":"Shaw","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib118","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in the Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib120","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindel\u00f6f","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib121","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib122","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib123","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamadermatol.2017.5801","article-title":"Prevalence and types of genital lesions in organ transplant recipients","volume":"154","author":"Nadhan","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib124","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/AOG.0000000000003378","article-title":"Lower genital tract dysplasia in female solid organ transplant recipients","volume":"134","author":"Thimm","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2026.03.078_bib125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/thoraxjnl-2021-218461","article-title":"Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients","volume":"77","author":"Thornton","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaad.2026.03.078_bib126","article-title":"Risk of human papillomavirus infection and cervical intraepithelial lesions in Chinese renal transplant recipients","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib127","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/tri.13493","article-title":"Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study","volume":"32","author":"Jambusaria-Pahlajani","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamadermatol.2022.3498","article-title":"Skin and UV Neoplasia transplant risk assessment calculator (SUNTRAC)-Keeping solid organ transplant recipients on track for skin cancer screening","volume":"159","author":"Kojder","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib129","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib130","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","article-title":"Sirolimus conversion for patients with posttransplant Kaposi's sarcoma","volume":"6","author":"Lebb\u00e9","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib131","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/1940-6207.CAPR-12-0272-T","article-title":"Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival","volume":"5","author":"Carr","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jaad.2026.03.078_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104562","article-title":"Cutaneous squamous cell carcinoma in the organ transplant recipient","volume":"103","author":"Bibee","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jaad.2026.03.078_bib133","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.healun.2018.03.012","article-title":"Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation","volume":"37","author":"Vos","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib134","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/CCID.S362171","article-title":"Immunomodulators for non-melanoma skin cancers: updated perspectives","volume":"16","author":"Russomanno","year":"2023","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-0012.2005.00412.x","article-title":"Systemic strategies for chemoprevention of skin cancers in transplant recipients","volume":"19","author":"Kovach","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2026.03.078_bib136","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJMe2214930","article-title":"Skin-Cancer chemoprevention in transplant recipients","volume":"388","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2026.03.078_bib137","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib138","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/TP.0b013e3182551021","article-title":"Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature","volume":"94","author":"Nashan","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2026.03.078_bib139","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaad.2018.11.032","article-title":"A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery","volume":"80","author":"Basu","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.03.078_bib140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1432-2277.2009.00858.x","article-title":"Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation","volume":"22","author":"Campistol","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2026.03.078_bib141","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjsurg.2012.11.018","article-title":"Corticosteroids and wound healing: clinical considerations in the perioperative period","volume":"206","author":"Wang","year":"2013","journal-title":"Am J Surg"},{"key":"10.1016\/j.jaad.2026.03.078_bib142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/DSS.0000000000004386","article-title":"Increased risk of postoperative complications in organ transplant recipients undergoing mohs micrographic surgery","volume":"51","author":"O'Donnell-Cappelli","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.03.078_bib143","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1524-4725.2012.02432.x","article-title":"Solid organ transplant recipients presenting for Mohs micrographic surgery: a retrospective case-control study","volume":"38","author":"Upjohn","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2026.03.078_bib144","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jdv.20103","article-title":"Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of mohs surgery)","volume":"39","author":"Abril-P\u00e9rez","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226004925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226004925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:42:40Z","timestamp":1793598160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226004925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0190962226004925"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.078","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive agents in solid organ transplantation: Cutaneous adverse effects and dermatologic considerations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.03.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}